The Current Ratio as of November 2025 (TTM) for Caplin Point Laboratories Limited (CAPPL.BO) is 5.80

According to Caplin Point Laboratories Limited’s latest financial reports and current stock price. The company's current Current Ratio is 5.80. This represents a change of 102.28% compared to the average of 2.87 of the last 4 quarters.

Caplin Point Laboratories Limited (CAPPL.BO) Historical Current Ratio (quarterly & annually)

How has CAPPL.BO Current Ratio performed in the past?

The mean historical Current Ratio of Caplin Point Laboratories Limited over the last ten years is 6.15. The current 5.80 Current Ratio has changed 9.34% with respect to the historical average. Over the past ten years (40 quarters), CAPPL.BO's Current Ratio was at its highest in in the March 2023 quarter at 5.80. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

Caplin Point Laboratories Limited (CAPPL.BO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Caplin Point Laboratories Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Caplin Point Laboratories Limited (CAPPL.BO) Average Current Ratio

How has CAPPL.BO Current Ratio performed in the past?

The current Current Ratio of Caplin Point Laboratories Limited (CAPPL.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Caplin Point Laboratories Limited (CAPPL.BO) Current Ratio vs. Peers

How is CAPPL.BO’s Current Ratio compared to its peers?

Caplin Point Laboratories Limited’s Current Ratio is greater than Glenmark Life Sciences Limited (4.52), greater than Glenmark Life Sciences Limited (4.52), greater than Novartis India Limited (5.54), greater than Lincoln Pharmaceuticals Limited (5.08), greater than Bafna Pharmaceuticals Limited (1.88), greater than Vivimed Labs Ltd. (0.80), greater than Ortin Laboratories Limited (3.11), greater than Ind-Swift Limited (1.42), greater than Ind-Swift Limited (1.42), greater than Parenteral Drugs (India) Ltd. (0.06),

Build a custom stock screener for Caplin Point Laboratories Limited (CAPPL.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caplin Point Laboratories Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Caplin Point Laboratories Limited (CAPPL.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Caplin Point Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.